title: Intravenous thrombolysis with recombinant tissue plasminogen activator in a stroke patient treated with dabigatran.
authors.affiliation: Department of Neurology, Universitair Ziekenhuis Brussel, Laarbeeklaan 101, Brussels, Belgium.
authors.forename: Ann
authors.initials: A
authors.lastname: De Smedt
authors.forename: Sylvie
authors.initials: S
authors.lastname: De Raedt
authors.forename: Koenraad
authors.initials: K
authors.lastname: Nieboer
authors.forename: Jacques
authors.initials: J
authors.lastname: De Keyser
authors.forename: Raf
authors.initials: R
authors.lastname: Brouns
mesh_terms: D000284:Administration, Oral; D000925:Anticoagulants / Q000008:administration & dosage / Q000627:therapeutic use*; D001562:Benzimidazoles / Q000008:administration & dosage / Q000627:therapeutic use*; D002533:Cerebral Angiography; D000069604:Dabigatran; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007275:Injections, Intravenous; D008875:Middle Aged; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000627:therapeutic use*; D020521:Stroke / Q000000981:diagnostic imaging / Q000188:drug therapy*; D015912:Thrombolytic Therapy; D010959:Tissue Plasminogen Activator / Q000008:administration & dosage / Q000627:therapeutic use*; D016896:Treatment Outcome; D015091:beta-Alanine / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use
chemical_list: D000925:Anticoagulants; D001562:Benzimidazoles; D011994:Recombinant Proteins; D015091:beta-Alanine; D010959:Tissue Plasminogen Activator; D000069604:Dabigatran